Indolor Therapeutics

Indolor Therapeutics is a healthcare subsidiary focused on pain management applications of EMulate Therapeutics' ultra-low radio frequency energy technology. The company appears to have been formed to create partnering and transactional flexibility for EMulate's pain-focused programs rather than to operate as a fully independent biotech company. Its approach uses a non-invasive wearable device to deliver information-based electromagnetic signal therapies instead of conventional drugs. Public disclosures indicate the program has generated encouraging preclinical data and limited human exposure data, with a stated focus on acute and chronic pain. Available evidence suggests Indolor is best characterized as an early-stage digital therapeutics or therapeutic device company rather than a traditional drug developer.